ArticleF1000Research2017

A Phase 2A randomized, double-blind, placebo-controlled pilot trial of GM604 in patients with Amyotrophic Lateral Sclerosis (ALS Protocol GALS-001) and a single compassionate patient treatment (Protocol GALS-C).

Mark Kindy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.